Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheena McCormack

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
Journal of the International AIDS Society|April 9, 2013
Microbicide clinical trial adherence: insights for introductionCynthia Woodsong, Kathleen MacQueen, K Rivet Amico, et al.
Sexually Transmitted Infections|February 13, 2025
Real-world experience of renal outcomes and management of PrEP users with estimated glomerular filtration rates less than 60 mL/min/1.73 m<sup>2</sup>Victoria Tittle, Nicolo Girometti, Jonathan Joseph Goodfellow, et al.
Sexually Transmitted Infections|March 29, 2019
Predictive factors for HIV infection among men who have sex with men and who are seeking PrEP: a secondary analysis of the PROUD trialEllen White, David T Dunn, Monica Desai, et al.
Sexual Health|September 26, 2018
Evolution of a pre-exposure prophylaxis (PrEP) service in a community-located sexual health clinic: concise report of the PrEPxpressNicolo Girometti, Sheena McCormack, Emma Devitt, et al.
Plos One|September 18, 2012
The implementation and appraisal of a novel confirmatory HIV-1 testing algorithm in the Microbicides Development Programme 301 Trial (MDP301)Ute Jentsch, Precious Lunga, Charles Lacey, et al.
BMJ Open|April 23, 2025
HIV risk perception, trust and PrEP adherence among participants in an HIV prevention trial: a qualitative longitudinal study, South AfricaRujeko Samanthia Chimukuche, Londiwe Shandu, Silindile Zulu, et al.
AIDS (London, England)|April 3, 2004
Long-term persistence of HIV-1 vaccine-induced CD4+CD45RA-CD62L-CCR7- memory T-helper cellsSunita S Balla-Jhagjhoorsingh, Gerrit Koopman, Petra Mooij, et al.
Research Involvement and Engagement|April 24, 2020
"PROUD to have been involved": an evaluation of participant and community involvement in the PROUD HIV prevention trialMitzy Gafos, Annabelle South, Bec Hanley, et al.
Sexually Transmitted Diseases|November 30, 2005
A dose-ranging phase I study of dextrin sulphate, a vaginal microbicide, in HIV-negative and HIV-positive female volunteersSheena McCormack, Vicky Jespers, Naomi Low-Beer, et al.
International Journal of STD & AIDS|September 21, 2017
Perceived need of, and interest in, HIV pre-exposure prophylaxis amongst men who have sex with men attending three sexual health clinics in London, UKLauren Bull, Pavle Dimitrijevic, Sophie Beverley, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Journal of the International AIDS Society|April 9, 2013
Microbicide clinical trial adherence: insights for introductionCynthia Woodsong, Kathleen MacQueen, K Rivet Amico, et al.
Sexually Transmitted Infections|February 13, 2025
Real-world experience of renal outcomes and management of PrEP users with estimated glomerular filtration rates less than 60 mL/min/1.73 m<sup>2</sup>Victoria Tittle, Nicolo Girometti, Jonathan Joseph Goodfellow, et al.
Sexually Transmitted Infections|March 29, 2019
Predictive factors for HIV infection among men who have sex with men and who are seeking PrEP: a secondary analysis of the PROUD trialEllen White, David T Dunn, Monica Desai, et al.
Sexual Health|September 26, 2018
Evolution of a pre-exposure prophylaxis (PrEP) service in a community-located sexual health clinic: concise report of the PrEPxpressNicolo Girometti, Sheena McCormack, Emma Devitt, et al.
Plos One|September 18, 2012
The implementation and appraisal of a novel confirmatory HIV-1 testing algorithm in the Microbicides Development Programme 301 Trial (MDP301)Ute Jentsch, Precious Lunga, Charles Lacey, et al.
BMJ Open|April 23, 2025
HIV risk perception, trust and PrEP adherence among participants in an HIV prevention trial: a qualitative longitudinal study, South AfricaRujeko Samanthia Chimukuche, Londiwe Shandu, Silindile Zulu, et al.
AIDS (London, England)|April 3, 2004
Long-term persistence of HIV-1 vaccine-induced CD4+CD45RA-CD62L-CCR7- memory T-helper cellsSunita S Balla-Jhagjhoorsingh, Gerrit Koopman, Petra Mooij, et al.
Research Involvement and Engagement|April 24, 2020
"PROUD to have been involved": an evaluation of participant and community involvement in the PROUD HIV prevention trialMitzy Gafos, Annabelle South, Bec Hanley, et al.
Sexually Transmitted Diseases|November 30, 2005
A dose-ranging phase I study of dextrin sulphate, a vaginal microbicide, in HIV-negative and HIV-positive female volunteersSheena McCormack, Vicky Jespers, Naomi Low-Beer, et al.
International Journal of STD & AIDS|September 21, 2017
Perceived need of, and interest in, HIV pre-exposure prophylaxis amongst men who have sex with men attending three sexual health clinics in London, UKLauren Bull, Pavle Dimitrijevic, Sophie Beverley, et al.
Pageof 12